CTC-clusters were more frequently observed in patients with luminal-like and triple negative BC than in patients with HER2-positive disease (median CTC-cluster number = 4, 5, and 0 for luminal-like, triple-negative, and HER2-positive BC respectively, p = 0.0467) (Figure 2D). This evidence concerns the gene ERBB2 and breast cancer.